Mereo BioPharma(US:MREO) Benzinga·2025-12-30 01:49Market Overview - Major U.S. indices closed lower, with the Dow Jones Industrial Average down 0.5% to 48,461.93, S&P 500 down 0.35% to 6,905.74, and Nasdaq down 0.5% to 23,474.34 [1] Brand Engagement Network Inc. - Brand Engagement Network stock surged by 108.75%, closing at $2.50, with an intraday high of $2.91 and a low of $1.77; the 52-week range is between $11.80 and $1.18 [1] - The significant rise followed the announcement of a Vendor Services Project Agreement with a major global advertising agency, involving a custom AI engagement solution for a top-10 pharmaceutical company's prescription drug, with revenue recognition expected in Q4 2025 [2] Ultragenyx Pharmaceutical Inc. - Ultragenyx Pharmaceutical shares plummeted by 42.32%, closing at $19.72, with a high of $20.49 and a low of $18.41; the 52-week range is from $46.50 to $18.41 [2] - The decline followed the disclosure of Phase 3 trial results for setrusumab (UX143) in osteogenesis imperfecta, a genetic bone disorder [3] Cemtrex Inc. - Cemtrex reported fiscal 2025 revenue of $76.5 million, up from $66.9 million a year earlier, returning to operating profitability with an operating income of $0.5 million compared to a $5.3 million loss in FY 2024 [4] - Both segments grew, with Security revenue rising 20% to $38.4 million and Industrial Services increasing 9% to $38 million; gross profit improved to $32.3 million, or 42% of revenue [4] - The company reduced debt by about $7.8 million and improved liquidity by roughly $9 million, strengthening its balance sheet [4] Sidus Space Inc. - Sidus Space stock jumped by 32.90%, closing at $2.56, with a high of $2.73 and a low of $2.20; the 52-week range is from $6.75 to $0.63 [5] - The company is set to close a public offering expected to raise about $16.2 million through the sale of 10.8 million Class A shares priced at $1.50 each, with funds allocated for working capital and general corporate purposes [6] - Momentum followed Sidus Space's selection as a contract awardee under the Missile Defense Agency's SHIELD IDIQ program, supporting the U.S. "Golden Dome" missile defense initiative [6] Tesla Inc. - Tesla shares declined by 3.27%, finishing at $459.64, with an intraday high of $469.40 and a low of $459; the 52-week range is from $498.82 to $214.25 [7] - The decline followed a new defect investigation by U.S. auto safety regulators into the 2022 Model 3 over concerns regarding the emergency door release [8]